Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Urinary Incontinence

In brief

The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.

Key facts

Study ID

NCT01340066

Run by

Beech Tree Labs, Inc.

People needed

94

Starts

2011-04-01

Expected to finish

2012-05-01

Last updated by the study team

2013-05-03

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who have moderate to severe urge, stress or mixed Urinary Incontinence

You may not qualify if…

• Medical history of migraines, neurologic problems, swallowing disorder, stroke or severe depression.
• Medical history of heart failure, peripheral edema or moderate to severe asthma or chronic obstructive pulmonary disease (COPD)
• Certain restricted medications
• Any other condition that would interfere with the safety of the subject

Where it is running

• Regional Clinical Research, Inc. — Endwell, New York, United States
• Rochester Clinical Research — Rochester, New York, United States
• PEAK Research, LLC — Upper Saint Clair, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.